9 20121127 pharmaq ms. kjersti gravningen

PHARMAQ The Blue Economy – sustainable Fisheries and

Aquaculture for Food Security - Jakarta, 27-11-2012

Kjersti Gravningen

PHARMAQ’s business idea

• We provide environmentally sound,

safe and efficacious health products

to the global aquaculture industry

through targeted research and the

commitment of dedicated people

Vaccination and disease control in Norwegian fish farming

Treatment Prevention

PHARMAQ in brief

• Head office in Norway

• Subsidiaries in the UK, Chile,

Turkey and Vietnam

• Distributors other countries

• 155 employees

• 20% of revenue allocated to

R&D (≈ USD 15 mill 2012)

• Export to >14 countries

• >60% market share

salmonids 2011

A knowledge driven company

PHARMAQ ASIA

PHARMAQ in Vietnam

• 100% owned by PHARMAQ AS

• Clinical R&D and S&M

• 16 employees

• Trained vaccination team

• Wet lab for clinical testing

• Diagnostic lab

Results– after vaccination of pangasius

against E. Ictaluri - field observation period

0,00

2,00

4,00

6,00

8,00

10,00

12,00

14,00

16,00

18,00

1 11 21 31

% m

ort

alit

y

Day post vaccination

0

5

10

15

20

25

30

35

40

45

1 11 21 31 41

% m

ort

alit

y

Day after vacciantion

R

V

R

R

V

Relevant experience in species and diseases

• Pangasius / catfish

• Asian Sea bass / Barramundi

• Tilapia

• Grouper

• Cobia

• Edwardsiella ictaliuri

• Aeromonas hydrophila

• Streptococcus agalactieae

• Streotococcus iniae

• Photobacterium damselae

• Flavobacterium /

Tenacibaculum sp.

• Vibrio sp

• VNN

Vaccination a good tool for the Blue economy

Vaccines increases

sustainability and

predictability

• Reduces mortality

• Reduces use of antibiotics

• Improve environment

• Improve growth

• Improve food safety

2010 2014

Grouper 7 20

Sea bass 5 8,5

Tilapia 492 1243

Catfish 495 2783

0

500

1000

1500

2000

2500

3000

3500

4000

4500

10

00

to

ns

Future production in Indonesia

Sugama 2011

– Collection of strains

– Clinical development

– Safety / Efficacy testing

– Field tests

– Sales

– Characterisation

– Process development

– Formulation

– Documentation

– Production

Vaccine development for new regions